What was THC Therapeutics’s price range in the past 12 months?
THC Therapeutics lowest stock price was $0.00 and its highest was $0.10 in the past 12 months.
What is THC Therapeutics’s market cap?
THC Therapeutics’s market cap is $87.93K.
When is THC Therapeutics’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is THC Therapeutics overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does THC Therapeutics pay dividends?
THC Therapeutics does not currently pay dividends.
What is THC Therapeutics’s EPS estimate?
THC Therapeutics’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does THC Therapeutics have?
THC Therapeutics has 43,966,150 shares outstanding.
Which hedge fund is a major shareholder of THC Therapeutics?
Currently, no hedge funds are holding shares in THCT
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
THC Therapeutics
THC Therapeutics, Inc. is a company active in the wellness sector, primarily engaged in developing the dHydronator. This innovative device functions as a sanitizing herb dryer, specifically designed for the efficient drying and cleansing of freshly harvested cannabis, as well as a variety of other herbs, flowers, and tea leaves. Established in 2007, the organization was initially known as Millennium Blockchain, Inc. before officially changing its name to THC Therapeutics, Inc. in September 2018. The company's corporate headquarters are located in Las Vegas, Nevada.